Globus Medical Inc- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Globus Medical Inc 公司

Globus Medical, Inc. 是一家医疗设备公司，致力于开发和商业化医疗保健解决方案，重点是改善肌肉骨骼疾病患者的生活质量。该公司提供一系列差异化技术，用于治疗各种肌肉骨骼疾病。肌肉骨骼解决方案主要包括用于一系列脊柱、骨科和神经外科手术的植入式设备、生物制剂、配件和手术器械。其脊柱产品可解决影响脊柱的大多数疾病，包括退行性疾病、畸形、肿瘤和创伤。该公司提供的解决方案可促进开放式和微创手术 (MIS) 技术。它包括传统的融合植入物，例如椎弓根螺钉和杆系统。其骨科创伤解决方案旨在治疗各种骨科骨折模式和上肢和下肢以及髋部的患者解剖结构。

公司简介

公司代码GMED

公司名称Globus Medical Inc

上市日期Mar 08, 2012

成立日期2003

CEOMr. Daniel T. (Dan) Scavilla

员工数量5300

证券类型Ordinary Share

年结日Mar 08

公司地址2560 General Armistead Ave

城市AUDUBON

上市交易所NYSE Consolidated

国家United States of America

邮编19403

电话16109301800

网址https://www.globusmedical.com/

公司代码GMED

上市日期Mar 08, 2012

成立日期2003

公司高管

名称

名称/职务

职务

持股

持股变动

Mr. David D. Davidar

Independent Director

685.24K

-6.86%

Ms. Ann D. Rhoads

Independent Director

35.38K

--

Mr. Daniel J. Wolterman

Independent Director

24.02K

--

Ms. Leslie V. Norwalk

Independent Director

16.42K

--

Mr. Robert Andrew (Rob) Douglas

Independent Director

2.00K

--

Mr. Brian Kearns

Investor Relations

--

Mr. Stephen T. (Steve) Zarrilli

Independent Director

--

Mr. James R. Tobin

Independent Director

--

Ms. Kelly Grace Huller, J.D.

Senior Vice President, General Counsel, Corporate Secretary

--

Mr. Daniel T. (Dan) Scavilla

President, Chief Executive Officer, Director

--

名称

名称/职务

职务

持股

持股变动

Mr. David D. Davidar

Independent Director

685.24K

-6.86%

Ms. Ann D. Rhoads

Independent Director

35.38K

--

Mr. Daniel J. Wolterman

Independent Director

24.02K

--

Ms. Leslie V. Norwalk

Independent Director

16.42K

--

Mr. Robert Andrew (Rob) Douglas

Independent Director

2.00K

--

Mr. Brian Kearns

Investor Relations

--

收入明细

单位: USD更新时间: 4月6日周日

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

业务USD

名称

营收

占比

Musculoskeletal Solutions products

2.37B

93.89%

Enabling Technologies products

154.00M

6.11%

地区USD

名称

营收

占比

United States

2.00B

79.39%

International

519.29M

20.61%

业务

地区

业务USD

名称

营收

占比

Musculoskeletal Solutions products

2.37B

93.89%

Enabling Technologies products

154.00M

6.11%

股东统计

更新时间: 2月21日周五

持股股东

股东类型

持股股东

股东统计

占比

The Vanguard Group, Inc.

9.60%

BlackRock Institutional Trust Company, N.A.

8.72%

Janus Henderson Investors

5.86%

State Street Global Advisors (US)

3.18%

JP Morgan Asset Management

2.32%

Other

70.32%

持股股东

股东统计

占比

The Vanguard Group, Inc.

9.60%

BlackRock Institutional Trust Company, N.A.

8.72%

Janus Henderson Investors

5.86%

State Street Global Advisors (US)

3.18%

JP Morgan Asset Management

2.32%

Other

70.32%

股东类型

股东统计

占比

Investment Advisor/Hedge Fund

41.80%

Investment Advisor

40.95%

Hedge Fund

11.08%

Pension Fund

2.17%

Sovereign Wealth Fund

1.33%

Bank and Trust

1.08%

Research Firm

1.00%

Individual Investor

0.69%

Venture Capital

0.22%

机构持股

更新时间: 1月20日周一

报告期

机构数

持股数

持股占比

持股变动

2025Q1

1002

114.23M

101.23%

-9.79M

2024Q4

1031

113.94M

83.15%

-12.71M

2024Q3

978

112.33M

98.84%

-21.04M

2024Q2

969

117.21M

103.71%

-15.66M

2024Q1

950

117.87M

104.30%

-9.50M

2023Q4

917

111.19M

96.81%

-13.25M

2023Q3

911

113.44M

96.67%

+12.22M

2023Q2

864

84.90M

108.73%

-4.84M

2023Q1

857

78.38M

100.58%

-6.61M

2022Q4

815

79.68M

102.42%

-5.05M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

The Vanguard Group, Inc.

10.84M

9.42%

+239.15K

+2.26%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

9.84M

8.55%

+310.21K

+3.25%

Dec 31, 2024

Janus Henderson Investors

6.61M

5.75%

-382.86K

-5.47%

Dec 31, 2024

State Street Global Advisors (US)

3.59M

3.12%

+23.74K

+0.66%

Dec 31, 2024

JP Morgan Asset Management

2.62M

2.28%

+190.79K

+7.84%

Dec 31, 2024

Burgundy Asset Management Ltd.

2.62M

2.27%

+43.33K

+1.68%

Dec 31, 2024

Citadel Advisors LLC

2.57M

2.23%

+985.04K

+62.08%

Dec 31, 2024

Wellington Management Company, LLP

2.50M

2.17%

-81.89K

-3.18%

Dec 31, 2024

Sculptor Capital Management, Inc

2.08M

1.81%

-132.90K

-6.01%

Dec 31, 2024

Geode Capital Management, L.L.C.

1.90M

1.65%

+12.15K

+0.64%

Dec 31, 2024

持股ETF

更新时间: 4月6日周日

机构名称

占比

Motley Fool Mid-Cap Growth ETF

4.77%

Motley Fool Small-Cap Growth ETF

4.47%

First Trust Nasdaq Lux Digi Health Solutions ETF

4.12%

ERShares Entrepreneurs ETF

2.19%

Alpha Architect U.S. Quantitative Momentum ETF

1.92%

Invesco S&P MidCap 400 Pure Growth ETF

1.85%

SPDR S&P Health Care Equipment ETF

1.57%

First Trust Indxx Medical Devices ETF

1.53%

ROBO Global Healthcare Technology & Innovation ETF

1.12%

ROBO Global Robotics and Automation Index ETF

1.11%

Motley Fool Mid-Cap Growth ETF

占比4.77%

Motley Fool Small-Cap Growth ETF

占比4.47%

First Trust Nasdaq Lux Digi Health Solutions ETF

占比4.12%

ERShares Entrepreneurs ETF

占比2.19%

Alpha Architect U.S. Quantitative Momentum ETF

占比1.92%

Invesco S&P MidCap 400 Pure Growth ETF

占比1.85%

SPDR S&P Health Care Equipment ETF

占比1.57%

First Trust Indxx Medical Devices ETF

占比1.53%

ROBO Global Healthcare Technology & Innovation ETF

占比1.12%

ROBO Global Robotics and Automation Index ETF

占比1.11%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

Globus Medical Inc

71.630USD

Globus Medical Inc

71.630

概览

公司